Introduction
============

Cardiovascular disease (CVD) is the main cause of mortality and morbidity in Brazil. It accounts for 20% of deaths in individuals over the age of 30 years, and its high prevalence is associated with inadequate control of risk factors. Identification of asymptomatic subjects at higher risk for CVD is a crucial step in public health policies, since effective control of these factors can reduce the mortality rate by up to 44%.^[@r1],[@r2]^

The presence of risk factors allows identifying individuals at higher cardiovascular risk (CVR). Nonetheless, intuitive estimates may either overestimate the low risk or underestimate the high risk, for not considering the interaction between them.^[@r3]^

A variety of scores have been developed for CVR stratification, such as the Framingham (FRC) and QRISK-2 (QRS) score, which estimate overall CVR in ten years. FRC was improved in 2008 m and has been widely used in Brazil and in the world along with aggravating factors. QRS was created in the UK, and has been used for cardiovascular prevention in primary care.^[@r4],[@r5]^

Despite its practicality and widespread use, FRS may underestimate or overestimate the risk in Hispanic and European populations. This fact motivated the development of QRS. However, studies have pointed out disagreements between both scores in estimating high risk, which may lead to the use of different therapies for the same patient.^[@r6]^

Considering both the importance of identifying asymptomatic patients at high risk for CVD, and therapeutic implications of each risk stratification score, we evaluated the degree of agreement between FRS and QRS in 10-year CVR in disease-free individuals attending a teaching hospital.

Methods
=======

Study design
------------

This was a cross-sectional, observational, descriptive, analytical study.

### Subjects

From January 2014 to January 2015, patients who attended scheduled appointments at the Internal Medicine outpatient clinic of a university hospital in the south of Brazil were invited to participate in the study. A total of 120 patients were assessed and, using a convenience sample, our final sample consisted of 74 patients.

Data collection instruments and procedure
-----------------------------------------

### Standard form

Data were obtained by interview with participants or from their medical records by medicine students. A standard form (Appendix I) was filled out with these data, including identification, clinical, and laboratory data, as follows.

**Identification** - Age (years), considering geriatric (≥ 60 years) and non-geriatric age (\< 60 years); sex (female or male); ethnicity (white or non-white); self-defined ethnicity (white or non-white); family income per dependent (self-reported income in minimum wages - MW, BRL724.00^[@r7]^ - divided by the number of family members), which was classified into high income (\> 1MW) or low income (≤ 1 MW); educational attainment - low educational attainment (primary education or none) and high educational attainment (from \'some high school education\' to \'bachelor\'s degree\').**Clinical examination** - History of CVD (left ventricular hypertrophy, angina and/or acute myocardial infarction; coronary revascularization or stent; congestive heart failure; intermittent claudication; stroke or transient ischemic attack); type 1 or type 2 diabetes mellitus (DM) (previous diagnosis or in treatment); treated systemic arterial hypertension (SAH) (previous diagnosis and/or use of anti-hypertensive drugs); history of premature coronary artery disease (CAD) (myocardial infarction or sudden death before the age of 55 of patient\'s father or other male first degree relative, or before the age of 65 of patient\'s mother or other female first degree relative);^[@r4]^ rheumatoid arthritis; atrial fibrillation; chronic kidney disease (previous diagnosis) and smoking - non-smokers or smokers (current smokers or who had quit smoking less than 2 years prior to the study).^[@r8]^ Weight (kg) and height (m) were measured using an anthropometric scale. Systolic arterial pressure (SAP) (mmHg) was measured with patient in the supine position, using an automatic, oscillatory, sphygmomanometer, after five minutes of rest. The highest SAP value between the two upper limbs was considered for analysis.^[@r9]^ Body mass index (BMI) was calculated considering overweight and obesity as BMI ≥ 25 kg/m^2^ and \> 30 kg/m^2^, respectively.^[@r10]^**Laboratory tests** - Lipid profile was analyzed by total cholesterol (TC) (mg/dL) and HDL cholesterol (HDL-c) (mg/dL) levels in the last 12 months. An altered lipid profile was considered as TC ≥ 240 mg/dl and/or HDL-c \< 40.^[@r3]^

### Risk stratification scores to estimate the 10-year overall CVR

#### Framingham risk score (FRS)

FRS estimates CVR based on the variables sex, age, SAP, SAH therapy, smoking, DM, HDL-c and TC. These data were used in the calculators available at Framingham Heart Study website.^[@r11]^

Individuals with a 10-year overall CVR ≥ 20% were classified as at high risk. Participants without recent data of lipid profile had their risk estimated by a calculator that used the BMI (in place of lipid data).^[@r12]^

#### QRISK-2 score (QRS)

QRS estimates CVR based on the variables gender, age, ethnicity, smoking, DM, family history of premature CAD, atrial fibrillation, SAH therapy, rheumatoid arthritis; chronic kidney disease; TC/HDL ratio and BMI. QRS was calculated using the risk calculator available at ClinRisk database website.^[@r13]^ Patients with a risk probability ≥ 20%^[@r14]^ were classified as at high risk ([Table 1](#t1){ref-type="table"}).

###### 

Characteristics of 10-year cardiovascular risk stratification tools

  **Score**                                                                  **Local/Studies on instrument derivation**                                                                                        **Age**       **Gender**        **Variables**                                                                                                                                                           **Outcomes**                                                                                                     **Risk**
  -------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------- ------------- ----------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------- ---------------------------------------------
  FRS, CVD in 10 years; 2 versions, FRS with lipid levels and FRS with BMI   8,491 participants, Framingham, Massachusetts, United Sates of America, 12 years of follow-up                                     30-74 years   Male and female   Age, gender, SAP, SAH treatment, TC, HDL-c, DM, smoking, BMI                                                                                                            10-year risk for AMI, coronary insufficiency, angina, ischemic stroke, hemorrhagic stroke, PAOD, heart failure   0-6% low; 6-20% moderate; ≥ 20% high
  QRS, CVD in 10 years                                                       2.3 million participants, QRESEARCH database (extracted from primary health care in the United Kingdom), 5.7 years of follow-up   25-84 years   Male and female   Age, gender, ethnics, zip code, smoking, DM, angina, family history of premature CAD in first-degree relative, CKD, AF, SAH treatment, RA, TC / HDL-c ratio, SAP, BMI   10-year risk for AMI, angina, CAD, stroke and TIS                                                                0-10% low; 10‑20% moderate; ≥ 20% high risk

FRS: Framingham risk score; QRS: QRISK-2 score; BMI: body mass index; SAP: systemic arterial pressure; SAH: systemic arterial hypertension; TC: total cholesterol; HDL-c: HDL-cholesterol; DM: Diabetes Mellitus; CAD: coronary artery disease; CKD: chronic kidney disease; AF: atrial fibrillation; RA: rheumatoid arthritis; TIS: transient ischemic stroke; PAOD: peripheral artery obstructive disease.

SOURCE: Framingham Heart Study
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Participants without recent lipid profile data had their risk determined by multiple imputation technique for missing data.

Criteria definition
-------------------

### Inclusion criteria

Patients of both sex aged between 30 and 74 years (which was the widest age range common for both scores) with no evidence of CVD were included.

### Exclusion criteria

Patients with CVD, out of the age range established by the online CVR calculators, or with missing or unreadable information in the medical records were not included in the study.

Statistical analysis
--------------------

Continuous variables with normal distribution (determined by the Kolmogorov-Smirnov test) were expressed as mean and standard deviation, whereas categorical variables as absolute frequency and proportion. Associations between variables were assessed by the chi-squared test (χ^2^), and statistically significant variables were adjusted by linear regression model, which considered the relationship between two risk strata (low/moderate *vs* high risk) as dependent variables. Models were adjusted by backward stepwise analysis and calculation of odds ratio (OR).

Kappa statistics was used to quantitatively assess the agreement between the scores. Kappa coefficients range from -1 to 1 and are classified, according to Landis & Rock (1977):^[@r15]^ \< 0, no agreement; 0-19, poor agreement; 0.20-0.39, fair agreement; 0.40-0.59, moderate agreement; 0.60-0.79, substantial agreement; 0.80-0.99, almost perfect agreement; 1, perfect agreement. Statistical significance was set at p \< 0.05, and analyses were performed using the SPSS® (Statistical Package for the Social Sciences), version 22.0.

Ethical aspects
---------------

The research was approved by the Ethics Committee (project number 1973.8713.8.0000.0121), and informed consent was obtained from all participants before entering the study.

Results
=======

A total of 120 patients were assessed, and the final sample consisted of 74 patients (33 were excluded for CVD and 13 were out of the pre-established age range). Sociodemographic, clinical and laboratory characteristics of patients are described in [Table 2](#t2){ref-type="table"}. Fourteen (19%) patients did not have recent data of lipid profile.

###### 

Sociodemographic, clinical and laboratory profile of the study population by continuous and categorical variables, University Hospital, Florianopolis, Brazil, 2015

  **Continuous variables (n = 74)**                    **Mean (**± **DP)**
  ---------------------------------------------------- ---------------------
  Age                                                  53.2 (± 11.0)
  SAP (mmHg)                                           141.52 (± 24.3)
  BMI (kg/m^2^)                                        28.4 (± 5.0)
  **Continuous variables (n = 60)**                    **Mean (± DP)**
  CT (mg/dl) [\*](#TFN2){ref-type="table-fn"}          195.46 (± 47.7)
  HDL-c[\*](#TFN2){ref-type="table-fn"}                52.0 (± 14.4)
  **Continuous variables (n = 64)**                    **Mean (± DP)**
  Family income [†](#TFN3){ref-type="table-fn"}        2073.1 (± 1267.1)
  **Categorical variables (n = 74)**                   **Total (%)**
  Elderly age range                                    21/74 (28.3)
  Female gender                                        48/74 (64.8)
  White race                                           68/74 (91.8)
  Low educational attainment                           57/74 (77.0)
  Smoking                                              10/74 (13.5)
  Elevated SAP                                         38/74 (51.3)
  Elevated BMI                                         57/74 (77.0)
  **Treated SAH**                                      35/74 (47.2)
      Female                                           23/48 (47.9)
      Male                                             12/26 (46.1)
      Geriatric                                        13/21 (61.9)
      Non-geriatric                                    22/53 (41.5)
  **Diabetes Mellitus**                                18/74 (24.3)
      Female                                           8/48 (16.7)
      Male                                             10/26 (38.5)
      Geriatric                                        8/21 (38.1)
      Non-geriatric                                    10/53 (18.9)
  **Categorical variables (n = 64)**                   **Total (%)**
  High family income [†](#TFN3){ref-type="table-fn"}   37/64 (57.8)

14 patients did not have recent lipid profile data;

10 patients did not declare their family income. SD: standard deviation; TC: total cholesterol; HDL-c: HDL -- cholesterol; SAP: systemic arterial pressure; BMI: body mass index; SAH: systemic arterial hypertension.

After risk stratification, low/moderate risk was predominant in both scores. The proportion of individuals classified as \'high risk\' was higher in FRS (33.7% vs 21.6%) ([Figure 1](#f1){ref-type="fig"}).

Figure 1Ten-year overall cardiovascular risk stratification. University Hospital, Florianopolis, Brazil, 2015.

In both instruments, percentages of male, white individuals, non-smokers, and individuals with high SAP and BMI were higher in the high-risk stratum and similar between both scores. DM patients and older hypertensive patients were predominant in QRS and FRS, respectively, in the same stratum ([Table 3](#t3){ref-type="table"}).

###### 

Distribution (relative and absolute frequencies) of independent variables in the high-risk stratum for cardiovascular disease, University Hospital, Florianopolis, Brazil, 2015

  Variables                    High risk     
  ---------------------------- ------------- --------------
  **Age**                                     
  Non-geriatric                48.0 \[12\]   31.3 \[5\]
  Geriatric                    52.0 \[13\]   68.6 \[11\]
  **Gender**                                  
  Male                         64.0 \[16\]   62.5 \[10\]
  Female                       36.0 \[9\]    37.5 \[6\]
  **Race**                                    
  White                        100 \[25\]    100.0 \[16\]
  Non-white                    0.0 \[0\]     0.0 \[0\]
  **Treated SAH**                             
  No                           24.0 \[6\]    12.5 \[2\]
  Yes                          76.0 \[19\]   97.5 \[14\]
  **Family history of PCAD**                  
  No                           72.0 \[18\]   62.5 \[10\]
  Yes                          28.0 \[7\]    37.5 \[6\]
  **Smoking**                                 
  No                           88.0 \[22\]   87.5 \[14\]
  Yes                          12.0 \[3\]    12.5 \[2\]
  **Diabetes Mellitus**                       
  No                           52.0 \[13\]   68.8 \[11\]
  Yes                          48.0 \[12\]   31.3 \[5\]
  **SAP**                                     
  Normal                       24.0 \[6\]    25.0 \[4\]
  Increased                    76.0 \[19\]   75.0 \[12\]
  **BMI**                                     
  Normal                       16.0 \[4\]    18.8 \[3\]
  Increased                    84.0 \[21\]   81.3 \[13\]

CVD: cardiovascular disease; SAH: systemic arterial hypertension; PCAD: premature coronary artery disease in first-degree relative; SAP: systemic arterial pressure; BMI: body mass index.

Kappa analysis revealed moderate agreement between FRS and QRS (K = 0.519; 95%CI 0.386-0.652; p \< 0.001).

In both instrument, significant relationships were observed between high-risk stratum and older age (FRS and QRS \[p \< 0.001 and p = 0.001\]), male sex (FRS and QRS \[p \< 0.001 and p = 0.001\]), treated SAH (FRS and QRS \[p \< 0.001 and p \< 0.001\]), DM (FRS and QRS \[p \< 0.001 and p \< 0.001\]), and elevated SAP (FRS and QRS \[p = 0.002 and p \< 0.003\]) ([Table 4](#t4){ref-type="table"}). OR was higher in the presence of these variables in both FRS and QRS, with statistically significant relationship ([Table 5](#t5){ref-type="table"}). In both scores, DM was associated with high risk, and in QRS, high risk was strongly related with treated SAH and older age ([Table 5](#t5){ref-type="table"}).

###### 

Bivariate analysis of independent variables in the high-risk stratum, University Hospital, Florianopolis, Brazil, 2015

  Variables                    Sample (%)\[n = 74\]   High risk                                                                     
  ---------------------------- ---------------------- ---------------------------------- ---------------------------------- ------- ----------
  **Age**                                                                                                                            
  Non-geriatric                71.6 \[53\]            10.36                              0.001                              16.37   \< 0.001
  Geriatric                    28.4 \[21\]                                                                                          
  **Gender**                                                                                                                         
  Male                         35.1 \[26\]            13.80                              \< 0.001                           6.70    0.01
  Female                       64.9 \[48\]                                                                                          
  **Race**                                                                                                                           
  White                        91.9 \[68\]            [††](#TFN7){ref-type="table-fn"}   [††](#TFN7){ref-type="table-fn"}   1.80    0.18
  Non-white                    8.1 \[6\]                                                                                            
  **Treated SAH**                                                                                                                    
  No                           52.7 \[39\]            12.47                              \< 0.001                           13.23   \< 0.001
  Yes                          47.3 \[35\]                                                                                          
  **Family history of PCAD**                                                                                                         
  No                           20.3 \[15\]            [††](#TFN7){ref-type="table-fn"}   [††](#TFN7){ref-type="table-fn"}   3.75    0.53
  Yes                          79.7 \[59\]                                                                                          
  **Smoking**                                                                                                                        
  No                           86.5 \[64\]            0.74                               0.78                               0.18    0.89
  Yes                          13.5 \[10\]                                                                                          
  **Diabetes Mellitus**                                                                                                              
  No                           75.7 \[56\]            15.71                              \< 0.001                           21.88   \< 0.001
  Yes                          24.3 \[18\]                                                                                          
  **SAP**                                                                                                                            
  Normal                       48.6 \[36\]            9.18                               0.002                              4.57    0.03
  Increased                    51.4 \[38\]                                                                                          
  **BMI**                                                                                                                            
  Normal                       23.0 \[17\]            1.03                               0.30                               0.20    0.65
  Increased                    77.0 \[57\]                                                                                          

\* Bracketed values indicate the absolute number of participants.

chi-squared test;

variables not predicted by Framingham risk score; SAH: systemic arterial hypertension; PCAD: premature coronary artery disease in first‑degree relative; SAP: systemic arterial pressure; BMI: body mass index.

###### 

Independent variables and high-risk chance, University Hospital, Florianopolis, Brazil, 2015

  Variables                          Score                                                 
  ---------------------------------- ------- ------------ ---------- ------- ------------- ----------
  **Low/Moderate *vs*. high risk**                                                          
  Male gender                        6.93    2.37-20.25   \< 0.001   4.37    1.365-14.02   0.013
  Geriatric age range                5.55    1.86-16.52   0.002      10.56   3.002-37.14   \< 0.001
  Treated SAH                        6.53    2.18-19.52   0.001      12.33   2.552-59.60   0.002
  Increased SAP                      5.00    1.69-14.76   0.004      3.69    1.064-12.81   0.04
  Diabetes mellitus                  9.53    2.83-32.06   \< 0.001   16.03   4.283-59.98   \< 0.001

Logistic regression analysis; OR: odds ratio; CI: confidence interval; SAH: systemic arterial hypertension; SAP: systolic arterial pressure.

Multivariate logistic regression revealed that male sex had a synergistic effect with SAH treatment in the high-risk stratus in both scores, and with older age in QRS. The variable SAP was excluded from the final model ([Table 6](#t6){ref-type="table"}).

###### 

Multivariate analysis between risk strata and independent variables, University Hospital, Florianopolis, Brazil, 2015

  Variables                                           Score                                              
  --------------------------------------------------- ------- ------------ ------- ------- ------------- -------
  **Low/Moderate *vs*. High risk**                                                                        
  Male gender                                         14.25   2.65-76.74   0.002   9.56    1.27-71.78    0.028
  Geriatric age range                                 4.74    1.19-18.89   0.028   19.58   2.69-142.78   0.003
  Treated SAH                                         10.79   1.88-61.88   0.008   19.22   1.76-210.41   0.015
  **Increased SAP[†](#TFN10){ref-type="table-fn"}**   \-      \-           \-      \-      \-            \-
  Diabetes mellitus                                   3.52    0.81-15.26   0.092   9.98    1.58-62.98    0.014

Logistic regression analysis;

increased SAP was removed from the model; OR: odds ratio; SAH: systemic arterial hypertension; SAP: systemic arterial pressure; CI: confidence interval.

Discussion
==========

CVR stratification scores are constructed from population-based cohort studies, via logistic regression analysis. Risk estimates may be influenced by many factors, including calendar year, geographic region, number of visits to physician assistant office, time of patients\' follow-up, quality of data collection, and prevalence of CVD risk factors. Therefore, agreement between scores, and consequently the number of individuals allocated in each risk stratum may vary substantially according to the score adopted,^[@r14]^ which was observed in this study. We found a moderate agreement (p \< 0.001) between FRS and QRS in the estimate of overall 10-year CVR, which is consistent with other similar studies in the literature.^[@r14],[@r16]^ However, a comparative study of North American and European risk scores, used in Latin American population, showed a weak agreement between scores.^[@r17]^ Thus, application of a score that had not been calibrated for the Brazilian population may lead to different therapeutic decisions.

CVR is estimated by the sum of the weights assigned to each risk factor, and multiplicative effect of these factors. Due to interaction complexity, intuitive risk estimates usually lead to underestimation or overestimation of data, and identification of these associations is made by risk scores.^[@r3]^ In the present study, FRS showed a fourteen-time higher risk for male individuals being classified as at high risk when the variable was associated with old age (OR 14.25; 95%CI 2.65-76.74; p = 0.002). QRS also showed increased probability of high risk for men (OR 9.56; 95%CI 1.27-71.78; p = 0.028) and hypertensive subjects (OR 19.22; 95%CI 1.76-210.41; p = 0.015), when associated with old age, suggesting a synergistic effect between these risk factors. The moderate agreement between the two scores used in this study may be partly due to these results, which is in agreement with the literature.^[@r5],[@r18]^

There was an agreement between FRS and QRS algorithms in grouping men with high SAP and BMI into high risk, indicated by the higher proportion of these categories in the stratum. Relatively more importance was given to older and hypertensive individuals by the QRS, since greater proportions of these subjects (68.6% and 97.5%, respectively) were found in the high-risk stratum. As compared with the FRS, the QRS adopts a wider age range (24-84 years) for risk calculation, and assigns more weight to age, which explains the greater proportion of elderly subjects considered as at high risk by the score. Similar trend was observed for SAH, due to its direct, linear relationship with age.^[@r9]^

The highest individual contribution to high risk was given by DM (FRS and QRS \[OR 9.53 and 16.03, respectively\]; p \< 0.001), indicating the need to identify and control this condition. However, the proportion of diabetics was higher in low/moderate risk strata, in contrast to the Adult Treatment Panel III and the Brazilian Society of Cardiology recommendations, which consider DM as a coronary disease, with high CVR.^[@r4],[@r19]^ These recommendations are questioned by some authors of prospective studies conducted in the United Kingdom (UK), who suggest that DM should be assessed according to the age of onset and disease duration for proper risk stratification.^[@r20]^ A systematic review indicates that CVR stratification scores currently available in the literature are able to stratify the risk in these patients, differently from other instruments specific for DM, and can be used in the making decision process. However, if the physician intends to calculate the risk, as part of preventive strategy to motivate the patients to change habits and adhere to treatment, an individualized, clinical assessment of patients, without the use of instruments dominated by fixed variables may be more adequate.^[@r21]^

Bivariate analysis showed that elderly age range and male sex are associated with high risk in both scores. Aging independently contributes to the increase of CVR in every decade of life, and is related to other conditions, including obesity, treated SAH, diabetes and dyslipidemia.^[@r22]^ Male gender is an independent risk variable for coronary disease, a frequent, early manifestation of CVD, commonly reported in population studies.^[@r12],[@r23],[@r24]^ The association of treated SAH, increased SAP and DM with high risk is in agreement with a multi-country, case-control study that identified these factors as major contributors to attributable risk for acute myocardial infarction (AMI).^[@r25]^ These findings suggest that preventive and therapeutic strategies may be used in different populations, aiming at preventing new cases of early IAM. Also, they may serve as a base for the use of FRS and QRS, even if they had not been calibrated for the Brazilian population, as an auxiliary tool for decision making in primary health care.

The relatively higher number of patients classified as at high risk by the FRS compared with QRS (33.7% versus 21.6%) is consistent with a study conducted in the United Kingdom, which suggests that the FRS may overestimate the risk by 5% in that population.^[@r5]^ A study analyzing the use of North American instruments in the UK population revealed that the scores overestimated the results by 25-115%. This variation may be justified by the fact that these tools derived from a cohort of predominantly white men decades ago, when the prevalence of CVD in the United States was higher than today.^[@r6]^

The QRISK-2 derives from a more recent and heterogeneous cohort in the UK, in a period when the prevalence of CVD has decreased. This may explain the lower proportion of patients in the high-risk stratum identified by this score.^[@r5]^ Other factors include the use of preventive therapies (aspirin, lipid-lowering and antihypertensive drugs), which reduce the incidence of CVD and modify the quantitative relationship between risk factors and cardiovascular events in an unpredictable manner, contributing to lower agreement between the instruments.^[@r6]^

The high proportion of individuals at high risk in both scores may be attributed to characteristics of the sample, which constituted patients attending a teaching hospital that treats highly complex cases, referred from the primary health care level.

In the present study, predominance of older (71.6%), female (64.86%) patients is similar to that observed in other patient groups in this outpatient care center^[@r26],[@r27]^ and in another Brazilian hospital.^[@r28]^ The predominance of white individuals (91.9%) is compatible with the 2010 census, conducted by the Brazilian Institute of Geography and Statistics, that reported a similar proportion in the city (94.47%).^[@r29]^

Low socioeconomic status (low income, low educational attainment and/or poor regions) is considered a psychosocial factor for CVD that negatively affects the adherence to a healthy life style, medical advice and treatment. The present study showed a predominance of patients with low educational attainment, and is consistent with another study performed in our center, showing an association between this variable and higher risk for hypertension. The higher proportion of high-income individuals may be associated with data bias due to the private nature of this question.

An Australian study^[@r30]^ related the high risk for cardiovascular disease with low socioeconomic status, suggesting the use of such association in the early detection and correct management of individuals at high risk. This strategy was successfully used in the UK, by using the QRISK-2 associated with Townsend index (which identifies each region by its zip code), and could be adapted to Brazil, in which primary healthcare centers are also strategically distributed, as in Australia and in the UK.

The elevated proportion of individuals with high SAH, SAP, overweight / obesity, and DM found in this institution reflects its position as a referral center, and corroborates the relevance of these modifiable risk factors in the study population. This may also justify the adoption of public health strategies focused on these factors.

There is as a considerable proportion of subjects without recent lipid levels (19%), which makes difficult the use of scores based on this laboratory parameter. Gaziano et al.^[@r31]^ found that the estimation of CVR by using easily obtained risk factors, such as arterial pressure, hypertension treatment, socioeconomic status, smoking, BMI and history family of DM, is able to estimate CVR as efficiently as laboratory tests, which is valuable for poorer areas. The authors also suggest the sedentary lifestyle, an important risk factor for CVD, may be included as a risk score, since it is influenced by behavior and due to the increasing prevalence of overweight/obesity worldwide. This was evidenced by a high proportion \[77.0% (57/74)\] of overweight/obesity detected in our study.

Limitations, contributions and future perspectives
--------------------------------------------------

This study used a convenience sample, which may not reflect the behavior of the general population. Also, analysis of the effect of the combination of DM and elevated SAP with the other variables in the multivariate analysis is limited by the small sample size. The study investigated characteristics of two instruments normally used in CVR stratification in patients attending the internal medicine outpatient care of a university hospital. These data may be used as a base for the development of instruments for cardiovascular prevention, specific for local reality.

Conclusion
==========

In our study population, there was a moderate correlation between FRS and QRS in estimating 10-year overall CVR. The scores assign different weights to the variables, which may have a synergistic effect and be affected by local population. This finding should be recognized for clinical purposes, as well as the need for calibrating risk scores for the Brazilian population.
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